Dermatologicals in Italy
Dermatologicals is expected to see moderate growth in current value terms in 2022, mostly thanks to consumers returning to more normal lifestyles, with the new variants of COVID-19 seen as less of a threat. Italy was hit by a new strong wave of COVID-19 in January 2022, but since then the threat from the pandemic is seen to have softened and the government has allowed for the easing of restrictions. This includes the re-opening of discos and clubs in February 2022 and the lifting of the obligati...
Euromonitor International's Dermatologicals in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook